Hemp Cos. Say DEA Overreached By Criminalizing HHC
Two hemp companies are challenging a recent U.S. Drug Enforcement Administration rule that designated a hemp-derived psychoactive compound as a Schedule I substance, saying the agency's move was an unlawful overreach...To view the full article, register now.
Already a subscriber? Click here to view full article